Synopsis

Source of validity: Scientific
Rating (out of 5): 2

Probiotics have been investigated as an adjunctive therapy for Giardia infections, particularly due to their potential to modulate the gut microbiota and enhance host immune responses. Several animal studies, particularly in mice and gerbils, have demonstrated that certain strains of Lactobacillus and Bifidobacterium can reduce the severity and duration of Giardia lamblia infection. The proposed mechanisms include competitive inhibition of pathogen adherence to the intestinal mucosa, enhancement of mucosal immune responses, and production of antimicrobial substances that may inhibit Giardia trophozoites.

Human data, however, are limited. A small number of clinical studies, such as a 2008 randomized controlled trial in children, have suggested that probiotics may reduce the duration of diarrhea in giardiasis when used alongside standard antigiardial therapy. However, these studies are generally small, sometimes lack rigorous controls, and often use probiotics as adjuncts rather than standalone treatments.

Overall, while there is some scientific rationale and preliminary data supporting the use of probiotics for Giardia, the evidence remains limited and is not sufficient for strong recommendations. Probiotics are generally considered safe, but they should not replace standard antiparasitic therapies. More well-designed, large-scale clinical trials are needed to establish their efficacy in treating giardiasis.

More about Probiotics
More about Giardia

Other ingredients used for Giardia

Other health conditions supported by Probiotics

Products containing Probiotics